Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)

BIOLOGICAL2 trials

Sponsors

Cellcolabs Clinical LTD.

Conditions

Cardiovascular DiseasesFrailty

Phase 1

A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging Frailty

Not yet recruitingNCT06070532

Cellcolabs Clinical LTD.Frailty

Start: 2025-01-01End: 2027-01-10Target: 12Updated: 2024-04-18

A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events

RecruitingNCT06087848

Cellcolabs Clinical LTD.Cardiovascular Diseases

Start: 2023-10-07End: 2029-10-06Target: 100Updated: 2024-04-19